Evaluation of Outcomes From Treatment of Benign or Malignant Gastrointestinal Diseases
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Gastrointestinal Disease
- Sponsor
- Methodist Health System
- Enrollment
- 1000
- Locations
- 2
- Primary Endpoint
- Overall symptom
- Status
- Enrolling By Invitation
- Last Updated
- 10 days ago
Overview
Brief Summary
This study will be a retrospective, registry study collecting data of patients who were diagnosed with benign or malignant gastrointestinal diseases. Data will be collected from patient's chart retrospectively once the patients have completed proper treatment follow up with physicians' practice.
Detailed Description
It is reported in the literature that the treatment of any gastrointestinal disease process, whether benign or malignant, continues to be a huge challenge. For example, patients with gastrointestinal cancer continue to be diagnosed at an advanced stage with medical and surgical options that are improving in terms of outcome measurements but with much more room for improvement. The goal is to continue to review our treatment outcomes to further improve overall survival, overall symptom control, mortality and morbidity. The main aim of this study is to evaluate and compare the outcomes from our treatment of benign or malignant gastrointestinal diseases through medical chart review. There is a need to understand and improve the current diagnosis and treatment algorithm for gastrointestinal pathologies. Continued evaluation and study is imperative to ensure that national guidelines are improving to enhance patient cure and/or recovery.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients diagnosed and treated for gastrointestinal diseases, benign or malignant from 2005 to
- •Age ≥18 years
Exclusion Criteria
- •Patients that are not diagnosed with or treated for gastrointestinal diseases
- •Age \<18 years
Outcomes
Primary Outcomes
Overall symptom
Time Frame: Jan 2005 - Jan 2030
Difficulty swallowing, Heartburn, Regurgitation, Chest pain, Weight Loss, Quality of life
Morbidity
Time Frame: Jan 2005 - Jan 2030
yes or no to individual disease
Overall survival
Time Frame: Jan 2005 - Jan 2030
from day of diagnosis or procedure to death date
Mortality
Time Frame: Jan 2005 - Jan 2030
death or life